Skin Tech Pharma Group, founded by Dr. Philippe Deprez in 1996 and headquartered in Spain, has entered into a strategic partnership with Charterhouse Capital Partners. Skin Tech is a B2B medical aesthetics firm specializing in the production of hyaluronic acid-based injectables, alongside other medical and cosmetic products. The firm offers a broad range of high-quality products manufactured in-house and marketed under its own brands. Additionally, Skin Tech engages in contract manufacturing. Its products are distributed in over 80 countries worldwide. This partnership signifies a significant step for both companies, aiming to leverage Charterhouse’s capital and expertise for global expansion and enhanced market reach.

Healthcare, Private Equity, Manufacturing,Spain, Global